Lightstone invests in five Indian companies
The Competition Commission of India (CCI) approved the acquisition by London-Luxembourg-based Lightstone Fund S.A., for and on behalf of the Lightstone Global Fund (LGT) of certain equity stakes in five Indian origin companies.
The companies are 91Streets Media Technologies Pvt Ltd, Ascent Health and Wellness Solutions Pvt Ltd, API Holdings Pvt Ltd (API), Aahaan Commercials Pvt Ltd and Lokprakash Vidhya Pvt Ltd, said the commission on announcing the approval under Section 31(1) of the Competition Act, 2002, on 26 August 2020.
Lightstone Fund is structured as a reserved alternative investment fund and was established as an umbrella fund structure with initially one sub-fund, i.e. Lightstone Global Fund.
Lightstone Fund S.A. is managed by its Alternative Investment Fund Manager i.e. LGT Capital Partners (Ireland) Limited.
91Streets, incorporated in India, operates on a pan-India basis directly and through its subsidiaries. 91Streets inter alia owns the technology and intellectual property required to develop an e-commerce platform (website as well as a mobile application), focusing on the sale of medicines and nutraceuticals by retailers/retail pharmacies with valid licenses, and diagnostic test package facilities offered by third-party labs. It also owns and develops a telemedical consultation platform.
Additionally, 91Street’s subsidiaries are engaged in the wholesale (Business to Business (B2B)) sale and distribution of pharmaceutical products, and sale to pharmaceutical retailers in India & in the provision of logistics delivery and transportation services.
Ascent, incorporated in India, operates on a pan-India basis directly and through its subsidiaries. These are inter alia engaged in the (online as well as offline) wholesale B2B sale and distribution of pharmaceutical, over the counter FMCG and nutraceutical products, on a cash and carry basis and in the business of owning and developing an application which provides an order management system for facilitating B2B sales in the pharmaceuticals industry.
API, incorporated in India, is not engaged in any business. In FY21, API, through its subsidiary, acquired a stake in Instinct Innovations Private Limited which is engaged in the business of developing software and enterprise resource planning solutions for healthcare business as well as non-healthcare space, inter alia, and customized application services for the retail pharmacies on which sales can also be made.
Aahaan & Lokprakash do not carry out any business activities and do not have any subsidiaries, according to the commission release. #merger&acquisition #banks #finance #investment #technologies /fiinews.com
